Erin Huiras Amerson

Erin Huiras Amerson

Auto-generated profile, based on publicly available information

Erin Huiras Amerson

Department of Dermatology, University of California, San Francisco, California

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
AZAdam Zakaria
Adam Zakaria
TMToby Maurer
Toby Maurer
GSGeorge Su
George Su
EAErin Amerson
Erin Amerson

1 January 2021 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
AZAdam Zakaria
Adam Zakaria
TMTheodore A. Miclau
Theodore A. Miclau
TMToby Maurer
Toby Maurer
KLKieron S. Leslie
Kieron S. Leslie
EAErin Amerson
Erin Amerson
Teledermatology (TD) enables remote evaluation and management of patients with dermatologic disease. Studies have found that TD improves patient access to care1-5 and clinical efficiency3,4,6-9 without forgoing diagnostic accuracy7,10,11 or negatively affecting patient experience.7,10,12,13 Despite the documented health and logistical benefits of TD, to our knowledge, literature on the cost-effectiveness of TD is scarce and has produced mixed results overall.9,10,14-30 Among studies evaluating TD within managed health care systems that would benefit most from improved cost-effectiveness, some have found TD to produce cost savings,15,17 others have found TD produces cost savings only when societal costs are included,16,23 and one has found TD to be more costly.21 Furthermore, only 2 studies incorporated the costs of managing dermatology patients after the initial consultation,16,23 and those studies excluded primary care follow-up costs associated with the management of the patient’s skin disease. We sought to address these gaps through a cost minimization analysis of the TD system at Zuckerberg San Francisco General Hospital and Trauma Center (hereafter referred to as the ZSFG) in California.

30 December 2022 in European Journal of Breast Health
Verified
Journal Article
Closed access
LCLe Wen Chiu
Le Wen Chiu
KGKaren Goodwin
Karen Goodwin
PVPoonam Vohra
Poonam Vohra
EAErin Amerson
Erin Amerson
Idiopathic granulomatous mastitis (IGM) is a rare, benign, inflammatory breast disease that primarily affects parous women within a period of five years post-partum. Cystic neutrophilic granulomatous mastitis (CNGM) is clinically identical to IGM, but histopathology demonstrates distinct central lipid vacuoles rimmed by neutrophils with an outer cuff of epithelioid histiocytes/granulomas, with inconsistent presence of Coryneform bacteria within the vacuoles. There is no consensus on the treatment for either IGM or CNGM, which may be managed surgically with wide local excision or mastectomy or medically with antibiotics, steroids, and steroid-sparing immunosuppressive agents. We present a 30-year-old woman with plaque psoriasis and CNGM whose breast symptoms resolved after treatment with the tumor necrosis factor alpha (TNF-α) inhibitor adalimumab, which has not previously been described as a treatment option for CNGM.

1 November 2022 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
EAErin H. Amerson
Erin H. Amerson
HVHerbert B. Castillo Valladares
Herbert B. Castillo Valladares
KLKieron S. Leslie
Kieron S. Leslie
Since its modern-day nadir of 5979 cases per year, or 2.1 cases per 100 000 population, in 2001, primary and secondary (PS) syphilis incidence has rapidly incre

1 December 2016 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
MLMichael Liu
Michael Liu
EMElizabeth Murphy
Elizabeth Murphy
EAErin Huiras Amerson
Erin Huiras Amerson

6 September 2021 in Telemedicine and e-Health
Verified
Journal Article
Closed access
AZAdam Zakaria
Adam Zakaria
TMToby Maurer
Toby Maurer
EAErin Amerson
Erin Amerson
Background: Despite many dermatology residency programs establishing teledermatology programs, few studies have analyzed its impact on resident education. Introduction: We evaluated the University of California, San Francisco School of Medicine teledermatology program at the Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG). We sought to evaluate resident perspectives on teledermatology and quantify its effects on the number of cases evaluated. Materials and Methods: Each week, dermatology residents triage new teledermatology referrals under the supervision of a dermatology attending. We anonymously surveyed dermatology residents and recent graduates who participated in teledermatology and evaluated responses through inductive thematic analysis. We also used administrative records to compare the productivity ratio (cases evaluated per hour) in clinic versus in teledermatology from June to December 2017. Results: Fifteen out of 21 (71%) potential respondents completed the survey. Five primary content areas emerged through the analysis, with teledermatology providing high caseload, a low-stress learning environment, and opportunities to consider a broad differential diagnoses while developing visual diagnostic and triaging skills. Residents had a productivity ratio of 4.55 (680.7 patients/149.7 h) in dermatology clinic versus 11.49 (299.7 patients/26.1 h) in teledermatology sessions. Discussion: Our thematic analysis to identify the most valued components of teledermatology is novel and can aid the design of teledermatology programs in other settings. We also found that residents evaluated twice the number of patient cases per unit time, with the implication that teledermatology can catalyze the development of visual morphology abilities. Conclusions: Teledermatology is viewed positively by dermatology residents and enables efficient case review by residents.